Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017 (2017), Article ID 6894040, 10 pages
https://doi.org/10.1155/2017/6894040
Research Article

Histopathological Changes in the Kidney following Congestive Heart Failure by Volume Overload in Rats

1Department of Anaesthesiology and Intensive Care Medicine, Charité University Berlin, Campus Virchow Klinikum and Campus Charité Mitte, Berlin, Germany
2Department of Anatomy, Ludwig-Maximilians-University Munich, Munich, Germany

Correspondence should be addressed to Shaaban A. Mousa; ed.etirahc@asuom.nabaahs

Received 22 February 2017; Revised 7 April 2017; Accepted 2 May 2017; Published 31 July 2017

Academic Editor: Sidhartha D. Ray

Copyright © 2017 Noureddin B. Aboryag et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. C. Fonarow, K. F. Adams Jr., W. T. Abraham, C. W. Yancy, W. J. Boscardin, and ADHERE Scientific Advisory Committee, Study Group, and Investigators, “Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis,” JAMA, vol. 293, no. 5, pp. 572–580, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. L. A. Allen, G. M. Felker, S. Pocock et al., “Liver function abnormalities and outcome in patients with chronic heart failure: data from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program,” European Journal of Heart Failure, vol. 11, no. 2, pp. 170–177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. R. de Silva, A. S. Rigby, K. K. Witte et al., “Anemia, renal dysfunction, and their interaction in patients with chronic heart failure,” The American Journal of Cardiology, vol. 98, no. 3, pp. 391–398, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Damman, G. Navis, A. A. Voors et al., “Worsening renal function and prognosis in heart failure: systematic review and meta-analysis,” Journal of Cardiac Failure, vol. 13, no. 8, pp. 599–608, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Ronco, A. A. House, and M. Haapio, “Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong,” Intensive Care Medicine, vol. 34, no. 5, pp. 957–962, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. P. A. McCullough, S. Steigerwalt, K. Tolia et al., “Cardiovascular disease in chronic kidney disease: data from the Kidney Early Evaluation Program (KEEP),” Current Diabetes Reports, vol. 11, no. 1, pp. 47–55, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Goldberg, H. Hammerman, S. Petcherski et al., “Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction,” American Heart Journal, vol. 150, no. 2, pp. 330–337, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. J. T. Heywood, “The cardiorenal syndrome: lessons from the ADHERE database and treatment options,” Heart Failure Reviews, vol. 9, no. 3, pp. 195–201, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. L. G. Bongartz, M. J. Cramer, P. A. Doevendans, J. A. Joles, and B. Braam, “The severe cardiorenal syndrome: ‘Guyton revisited’,” European Heart Journal, vol. 26, no. 1, pp. 11–17, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Y. Goh, G. Vizzi, M. De Cal, and C. Ronco, “Cardiorenal syndrome: a complex series of combined heart/kidney disorders,” Contributions to Nephrology, vol. 174, pp. 33–45, 2011. View at Google Scholar
  11. E. Cho, M. Kim, Y. S. Ko et al., “Role of inflammation in the pathogenesis of cardiorenal syndrome in a rat myocardial infarction model,” Nephrology, Dialysis, Transplantation, vol. 28, no. 11, pp. 2766–2778, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. D. R. Green, “Apoptotic pathways: paper wraps stone blunts scissors,” Cell, vol. 102, no. 1, pp. 1–4, 2000. View at Publisher · View at Google Scholar
  13. I. Budihardjo, H. Oliver, M. Lutter, X. Luo, and X. Wang, “Biochemical pathways of caspase activation during apoptosis,” Annual Review of Cell and Developmental Biology, vol. 15, pp. 269–290, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Deng, G. Wang, Q. Huang et al., “Oxidative stress-induced leaky sarcoplasmic reticulum underlying acute heart failure in severe burn trauma,” Free Radical Biology & Medicine, vol. 44, no. 3, pp. 375–385, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Guo, W. Zhang, Y. Y. Yan et al., “Triterpenoid pristimerin induced HepG2 cells apoptosis through ROS-mediated mitochondrial dysfunction,” Journal of BUON, vol. 18, no. 2, pp. 477–485, 2013. View at Google Scholar
  16. R. Garcia and S. Diebold, “Simple, rapid, and effective method of producing aortocaval shunts in the rat,” Cardiovascular Research, vol. 24, no. 5, pp. 430–432, 1990. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Treskatsch, A. Feldheiser, A. T. Rosin et al., “A modified approach to induce predictable congestive heart failure by volume overload in rats,” PLoS One, vol. 9, no. 1, article e87531, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. M. R. Dent, P. S. Tappia, and N. S. Dhalla, “Gender differences in cardiac dysfunction and remodeling due to volume overload,” Journal of Cardiac Failure, vol. 16, no. 5, pp. 439–449, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Pacher, T. Nagayama, P. Mukhopadhyay, S. Bátkai, and D. A. Kass, “Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats,” Nature Protocols, vol. 3, no. 9, pp. 1422–1434, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. D. C. Saha, A. C. Saha, G. Malik, M. E. Astiz, and E. C. Rackow, “Comparison of cardiovascular effects of tiletamine-zolazepam, pentobarbital, and ketamine-xylazine in male rats,” Journal of the American Association for Laboratory Animal Science, vol. 46, no. 2, pp. 74–80, 2007. View at Google Scholar
  21. S. Treskatsch, M. Shakibaei, A. Feldheiser et al., “Ultrastructural changes associated with myocardial apoptosis, in failing rat hearts induced by volume overload,” International Journal of Cardiology, vol. 197, pp. 327–332, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Mayer, “Ueber das Faerben mit Haematoxylin,” Mittheilungen aus der Zoologischen Station zu Neapal, vol. 10, no. 10, pp. 170–186, 1981. View at Google Scholar
  23. S. A. Mousa, M. Shakibaei, N. Sitte, M. Schäfer, and C. Stein, “Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain,” Endocrinology, vol. 145, no. 3, pp. 1331–1341, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. S. A. Mousa, M. Shaqura, J. Winkler et al., “Protein kinase C-mediated mu-opioid receptor phosphorylation and desensitization in rats, and its prevention during early diabetes,” Pain, vol. 157, no. 4, pp. 910–921, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Shaqura, X. Li, M. Al-Khrasani et al., “Membrane-bound glucocorticoid receptors on distinct nociceptive neurons as potential targets for pain control through rapid non-genomic effects,” Neuropharmacology, vol. 111, pp. 1–13, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. E. M. Manders, F. J. Verbeek, and J. A. Aten, “Measurement of colocalization of objects in dual-color confocal images,” Journal of Microscopy Oxford, vol. 169, pp. 375–382, 1993. View at Google Scholar
  27. C. W. Yancy, M. Jessup, B. Bozkurt et al., “2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,” Journal of the American College of Cardiology, vol. 62, no. 16, pp. e147–e239, 2013. View at Google Scholar
  28. C. P. Li, J. H. Li, S. Y. He, P. Li, and X. L. Zhong, “Roles of Fas/Fasl, Bcl-2/Bax, and caspase-8 in rat nonalcoholic fatty liver disease pathogenesis,” Genetics and Molecular Research, vol. 13, no. 2, pp. 3991–3999, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Bang, R. Gniadecki, and B. Gajkowska, “Disruption of lipid rafts causes apoptotic cell death in HaCaT keratinocytes,” Experimental Dermatology, vol. 14, no. 4, pp. 266–272, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Yang, Y. H. Liu, X. P. Yang, J. Xu, A. Kapke, and O. A. Carretero, “Myocardial infarction and cardiac remodelling in mice,” Experimental Physiology, vol. 87, no. 5, pp. 547–555, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. W. K. Lee, U. Bork, and F. Thevenod, “Mitochondria as a target of cadmium nephrotoxicity: induction of swelling and cytochrome C release,” Toxicology Mechanisms and Methods, vol. 14, no. 1-2, pp. 67–71, 2004. View at Google Scholar
  32. W. Z. Ying and P. W. Sanders, “Cytochrome c mediates apoptosis in hypertensive nephrosclerosis in Dahl/Rapp rats,” Kidney International, vol. 59, no. 2, pp. 662–672, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. G. P. Kaushal, V. Kaushal, X. Hong, and S. V. Shah, “Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells,” Kidney International, vol. 60, no. 5, pp. 1726–1736, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. M. A. Azad, J. Akter, K. L. Rogers, R. L. Nation, T. Velkov, and J. Li, “Major pathways of polymyxin-induced apoptosis in rat kidney proximal tubular cells,” Antimicrobial Agents and Chemotherapy, vol. 59, no. 4, pp. 2136–2143, 2015. View at Publisher · View at Google Scholar · View at Scopus